Profound Medical Corp. logo
Profound Medical Corp. PROF
$ 7.26 5.99%
report update icon

Quarterly report 2026-Q1
added 05-07-2026

Profound Medical Corp. Net Debt | PROF

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Profound Medical Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-55 M -51.7 M -21 M -39.1 M - - -7.36 M -18.7 M -5.96 M -10.6 M -3.37 M 1.31 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.31 M -55 M -21.1 M

References

  1. Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Medical devices industry

Issuer Net Debt Price % 24h Market Cap Country
Cutera Cutera
CUTR
-140 M - -10.19 % $ 1.99 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-26.7 M - - $ 162 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
38.7 M - - $ 1.77 B usaUSA
Avinger Avinger
AVGR
-12.4 M - -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-77.2 M - - $ 3.31 B usaUSA
Eargo Eargo
EAR
-97.8 M - - $ 10.2 M usaUSA
LENSAR LENSAR
LNSR
-10.2 M $ 5.6 -2.78 % $ 67 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-3.31 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
6.46 M - -5.86 % $ 30.6 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-22.5 M - - $ 475 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
-32.4 M - 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
252 K - 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
6.1 M - -13.19 % $ 166 K usaUSA
Outset Medical Outset Medical
OM
63 M $ 4.04 -4.49 % $ 61.5 K usaUSA
AxoGen AxoGen
AXGN
15.2 M $ 39.49 -0.6 % $ 1.82 B usaUSA
Conformis Conformis
CFMS
-26.2 M - - $ 16.4 M usaUSA
Insulet Corporation Insulet Corporation
PODD
218 M $ 163.26 3.08 % $ 11.5 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
-64.6 M - 0.15 % $ 844 M usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
7.4 M $ 3.67 -6.38 % $ 156 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
230 M - -4.14 % $ 702 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
1.59 B $ 60.45 -2.74 % $ 9.18 B usaUSA
Sintx Technologies Sintx Technologies
SINT
-898 K $ 1.42 -6.58 % $ 3.94 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-31.6 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.02 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-2.3 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
5.72 M - - $ 462 M usaUSA
TELA Bio TELA Bio
TELA
5.33 M $ 0.69 -2.81 % $ 32.4 M usaUSA
Neovasc Neovasc
NVCN
-51 M - - $ 111 M canadaCanada
Dynatronics Corporation Dynatronics Corporation
DYNT
1.8 M - 14.99 % $ 929 K usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
-75.4 M $ 27.48 0.15 % $ 629 M usaUSA
TransMedics Group TransMedics Group
TMDX
-32.3 M $ 72.26 1.59 % $ 2.46 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-5.23 M $ 0.89 -3.38 % $ 15.1 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
239 M $ 17.12 1.3 % $ 1.16 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.8 M - - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
2.62 M - -0.97 % $ 54.4 M usaUSA
GBS GBS
GBS
-4.38 M - -0.57 % $ 7.12 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
3.85 M $ 14.12 -2.55 % $ 400 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
-1.01 M $ 11.77 0.86 % $ 458 M usaUSA
Avanos Medical Avanos Medical
AVNS
8.7 M $ 24.99 0.04 % $ 1.16 B usaUSA
Beyond Air Beyond Air
XAIR
-5.4 M $ 5.16 -5.67 % $ 42.8 B usaUSA
Invacare Corporation Invacare Corporation
IVC
299 M - - $ 24.7 M usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
-5.4 M $ 0.43 -0.39 % $ 60 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
11 M $ 0.36 -0.39 % $ 22.4 M usaUSA
NanoVibronix NanoVibronix
NAOV
-4.11 M - - $ 1.08 M usaUSA
NuVasive NuVasive
NUVA
-238 M - - $ 2.07 B usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
-64.1 M - 1.94 % $ 1.05 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
93.4 M - - $ 217 M usaUSA
Inogen Inogen
INGN
-86.3 M $ 6.15 -2.69 % $ 164 M usaUSA